Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma

Uterine leiomyoma (UL) is one of the most common benign tumors in women that often leads to many reproductive complications. Suicide genetherapy was suggested as a promising approach for UL treatment. In the present study, we describe iRGD ligand-conjugated cysteine-rich peptide carrier RGD1-R6 for...

Descripción completa

Detalles Bibliográficos
Autores principales: Egorova, Anna, Shtykalova, Sofia, Selutin, Alexander, Shved, Natalia, Maretina, Marianna, Selkov, Sergei, Baranov, Vladislav, Kiselev, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913275/
https://www.ncbi.nlm.nih.gov/pubmed/33540912
http://dx.doi.org/10.3390/pharmaceutics13020202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913275/
https://www.ncbi.nlm.nih.gov/pubmed/33540912
http://dx.doi.org/10.3390/pharmaceutics13020202

Ejemplares similares